normal phenotype
• mice are viable with no obvious phenotypic or behavioral abnormalities
|
Allele Symbol Allele Name Allele ID |
Calca+ wild type MGI:2440052 |
||||||||||||||||||||||||
Summary |
5 genotypes
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• mice are viable with no obvious phenotypic or behavioral abnormalities
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• when neurons of the outer external lateral subdivision of the PBN (PBelo) are transduced with a cre-dependent channelrhodopsin-mCherry vector, photostimulation of projections to the central nucleus of the amygdala (CeAlc) reversibly suppressed food intake in animals whereas stimulation of PBelo projections to the bed nucleus of the stria terminalis (BNST) does not alter food intake significantly
|
• in mice injected with a cre-dependent channelrhodopsin (ChR2)-mCherry vector, optical stimulation of transduced fibers in the central nucleus of the amygdala (CeAlc) induces excitatory postsynaptic currents as well as increased firing rates in these neurons in acute brain slices
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• death within 3 months of tamoxifen treatment
|
• small cell lung tumors 2.5 months after tamoxifen treatment
|
• increased proliferation of pulmonary neuroendocrine cells
|
• all mice develop thyroid tumors
|
• increased invasiveness at 2.5 months after tamoxifen treatment
|
• small cell lung tumors 2.5 months after tamoxifen treatment
|
• all mice develop thyroid tumors
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• death within 6-7 months of tamoxifen treatment
|
• small cell lung tumors 5-6 months after tamoxifen treatment in 4 of 32 mice examined, all with pulmonary neuroendocrine cells hyperplasia as well
|
• pulmonary neuroendocrine cells hyperplasia 5-6 months after tamoxifen treatment in 16 of 32 mice examined
• increased proliferation of pulmonary neuroendocrine cells
|
• all mice develop thyroid tumors
|
• small cell lung tumors 5-6 months after tamoxifen treatment in 4 of 32 mice examined, all with pulmonary neuroendocrine cells hyperplasia as well
|
• all mice develop thyroid tumors
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• clara cell numbers recover after tamoxifen and/or naphthalene lung injury regardless of presence or absence of pulmonary neuroendocrine cells
|
• pulmonary neuroendocrine cells ablated by tamoxifen treatment are not replaced at 1, 6, 10, and 12 months after treatment
• naphthalene lung injury fails to induce restoration of this cell type
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 03/25/2025 MGI 6.24 |
![]() |
|